RPS 116 - Staging, metastases and response assessment

Undifferentiated pleomorphic sarcoma: Building an effective multi-parametric MRI (mpMRI) predictive treatment response model to replace RECIST

Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy. Final results of ISG-STS 1001, a randomized clinical trial

MRI-based Multiregional Radiomics for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: a bicenter study

Can a fast T2-Dixon sequence surpass the time obstacle of whole-body MRI in the evaluation of skeletal metastases?

Can spectral computed tomography (CT) replace perfusion CT to evaluate the lymphovascular and perineural invasion of gastric cancer?

Impact of reader experience on reader agreement for whole-body MRI staging of oesophageal cancer

Observer variability and reproducibility of bone marrow metastasis biomarkers on MRI

Spectral CT imaging for assessment of metastases in melanoma patients: Multi-reader evaluation

Accuracy of DOTATATE PET CT versus DOTATATE PET MR in the Assessment of Multifocal Small Bowel Neuroendocrine Neoplasm

Discord Dilemmas in Lung Cancer Clinical Trials: Navigating Reader Variability in Response Assessment

Detection of abdominal metastases in brain tumor patients following ventriculoperitoneal shunting

Imaging treatment response in High Grade Serous Ovarian Cancer: Metabolic imaging vs Cell death imaging